Yahoo
OTC Markets OTCQB - Delayed Quote USD

DIAGNOS Inc. (DGNOF)

0.2740 -0.0020 (-0.72%)
At close: 1:39:31 PM EDT
Chart Range Bar
Loading chart for DGNOF
  • Previous Close 0.2760
  • Open 0.2760
  • Bid 0.2729 x 1500000
  • Ask 0.2800 x 500000
  • Day's Range 0.2740 - 0.2760
  • 52 Week Range 0.1300 - 0.3800
  • Volume 92,468
  • Avg. Volume 104,268
  • Market Cap (intraday) 33.164M
  • Beta (5Y Monthly) 0.08
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0300
  • Earnings Date (est.) Oct 20, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, and internationally. It offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy, as well as allows eye care specialists to visualize normal retinal landmarks and pathological changes. The company also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

diagnosmedical.com

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/20/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

DGNOF
5.38%
S&P/TSX Composite index (^GSPTSE)
13.31%

1-Year Return

DGNOF
5.38%
S&P/TSX Composite index (^GSPTSE)
18.71%

3-Year Return

DGNOF
14.38%
S&P/TSX Composite index (^GSPTSE)
88.89%

5-Year Return

DGNOF
31.50%
S&P/TSX Composite index (^GSPTSE)
70.42%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY25
Revenue 22.67k
Earnings --
Profit Margin 0.00%

Q2

FY24

Q3

FY24

Q1

FY25

Q2

FY25

0
10K
20K
30K
40K
50K
0.0%

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    41.73M

  • Enterprise Value

    41.36M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    788.22

  • Price/Book (mrq)

    84.30

  • Enterprise Value/Revenue

    888.51

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -88.42%

  • Return on Equity (ttm)

    -990.25%

  • Revenue (ttm)

    65.48k

  • Net Income Avi to Common (ttm)

    -4.56M

  • Diluted EPS (ttm)

    -0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.93M

  • Total Debt/Equity (mrq)

    204.05%

  • Levered Free Cash Flow (ttm)

    -2.47M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: